Ra Medical Systems, Inc.
2070 Las Palmas Drive
Carlsbad, California 92011
February 1, 2022
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attn: | Gary Guttenberg |
| Re: | Ra Medical Systems, Inc. |
|
| Registration Statement on Form S-1 File No. 333-262195 |
|
| Acceleration Request Requested Date: February 3, 2022 Requested Time: 5:00 p.m. Eastern Time
|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ra Medical Systems, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l, as amended (File No. 333-262195) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). The Company hereby authorizes Eric Y. Hsu of Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel for the Company, to make such request on the Company’s behalf.
The Company acknowledges that should the Commission or its Staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing. In addition, the Company acknowledges that the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing. Finally, the Company acknowledges that it may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The Company requests that it be notified of the effectiveness of the Registration Statement by telephone to Eric Y. Hsu of Wilson Sonsini Goodrich & Rosati, Professional Corporation at (650) 849-3305 or via email at ehsu@wsgr.com. If notice of effectiveness is given by telephone, please also provide a copy of the Commission’s order declaring the Registration Statement effective to Eric Y. Hsu via facsimile at (650) 493-6811.
Please direct any questions or comments regarding this acceleration request to Eric Y. Hsu at (650) 849-3305.
U.S. Securities and Exchange Commission
February 1, 2022
Page 2
|
|
|
|
| ||
Sincerely,
RA MEDICAL SYSTEMS, INC. | ||||||
|
| |||||
By: |
| /s/ Andrew Jackson | ||||
|
| Name: |
| Andrew Jackson | ||
|
| Title: |
| Chief Financial Officer | ||
|
| |||||
cc: | Martin J. Waters, Esq. Eric Y. Hsu, Esq. Robert L. Wernli, Jr., Esq. | |||||
| Wilson Sonsini Goodrich & Rosati, Professional Corporation | |||||
